TGen News & Press Releases : TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of molecular profiling and proteomic mapping

TGen News & Press Releases

TGen and ABL pursue global rollout of advanced TB test

Posted Monday March 18, 2019

Licensing agreement puts DeepChek®-TB one step closer to clinical application

Outbreak of paralyzing disease linked to non-polio enterovirus through TGen-led study

Posted Tuesday January 22, 2019

EV-D68 is confirmed among AFM patients at Phoenix-area hospital

NAU-TGen study finds West Nile Virus now a permanent part of Arizona ecosystem

Posted Tuesday January 15, 2019

New technology allows better tracking of potentially deadly infection

Flinn Foundation awards ‘Prevent HAARM’ grant to C-Path and TGen

Posted Tuesday January 8, 2019

$400,000 grant aims to develop a genomic surveillance system to respond to antimicrobial resistant pathogens

TGen North partners with NARBHA Institute to promote human health

Posted Wednesday November 14, 2018

‘TGen One Health Collaborative’ uses holistic approach to connect human health and the environment

TGen launches new discovery platform to guard human health

Posted Monday April 2, 2018

Clinical Microbiome Services Center enhances TGen’s genomic analyses

How did a deadly tropical fungus get to the temperate environs of the Pacific Northwest?

Posted Wednesday January 17, 2018

TGen-led study points to opening of the Panama Canal as the gateway of pathogen migration from Brazil to Canada

DxNA LLC receives a de novo regulatory clearance by the FDA for the GeneSTAT.MDx™ Coccidioides Test on the GeneSTAT® Analyzer - the only FDA cleared molecular test for Valley Fever

Posted Wednesday December 6, 2017

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley Fever.

TGen is one of 25 research groups sharing $9 million to combat drug-resistant bacteria

Posted Monday October 23, 2017

U.S. Centers for Disease Control announces creation of pilot projects geared to protect public health

TGen sequencing test enables precise identification of drug-resistant TB

Posted Monday October 9, 2017

UCSF and TGen researchers advance SMOR testing, with an eye on precision medicine for tuberculosis

Prev
[1]
2
3
Next

Search

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

Newsletter

News Archive

View Media Release Archive